Filing Details

Accession Number:
0001209191-15-085761
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-12-17 16:06:42
Reporting Period:
2015-11-10
Filing Date:
2015-12-17
Accepted Time:
2015-12-17 16:06:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1422143 Kura Oncology Inc. KURA Pharmaceutical Preparations (2834) 611547851
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1403322 Thomas Malley Kura Oncology, Inc.
11119 N. Torrey Pines Road, Suite 125
San Diego CA 92037
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-11-10 50,000 $8.00 89,557 No 4 P Indirect By Mossrock Capital, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Mossrock Capital, LLC
Footnotes
  1. Mr. Malley serves as President of Mossrock Capital, LLC and has sole voting and investment power over these shares.